DAXX and breast neuroendocrine neoplasm: Likewise, MEN1 (6%) and DAXX (2%) had rarely pathogenetic or unknown variants in breast NETs, with pathogenetic or unknown variant rates of 37% and 22% in PNETs (Fig. 3B).